Core Viewpoint - The European Union has decided to restrict Chinese companies from participating in medical device tenders exceeding 5 million euros, citing the International Procurement Instrument (IPI) as the basis for this decision. This move is perceived by China as unfair competition disguised as fair competition, and the Chinese government has vowed to protect the legitimate rights of its enterprises [1][3]. Group 1: Background and Context - The IPI was first proposed in 2012 and implemented in June 2022, allowing the EU to exclude companies from certain countries from large public tenders or impose punitive adjustments on their bids, potentially increasing them by 10%-20% [3]. - The restriction primarily affects high-end medical equipment contracts, such as proton therapy systems and advanced imaging devices, which are not common globally, including in China [6]. Group 2: Market Impact - The immediate industry reaction was one of concern, but this was quickly tempered as the actual impact of the regulation is considered limited. The majority of contracts above 40 million RMB are rare, and the EU market is largely a replacement market with limited new contracts [5][6]. - Chinese medical device companies are still in the early stages of international expansion and lack the long-term trust relationships with local public healthcare institutions that established companies like Siemens and Philips have [6]. Group 3: Historical Development of Chinese Medical Device Exports - The export journey of Chinese medical devices can be divided into three phases: 1. From the late 1990s to 2008, focusing on low-value consumables and simple diagnostic devices, with minimal technical content [7]. 2. From 2009 to 2015, where companies began to move beyond OEM and private label, increasing the export of mid-to-high-end devices [8]. 3. From 2016 to present, where there has been a significant output of low-value consumables alongside breakthroughs in high-end equipment, with a focus on localization in target markets to adapt to protectionist policies [8].

Core Viewpoint - Recently, the Aerospace Information University announced multiple government procurement intentions, with a total budget of 243 million yuan for six types of instrument equipment [1][2]. Group 1: Procurement Overview - The total budget for the procurement intentions is 243 million yuan, covering various advanced instruments including FIB+SEM, laser confocal microscopes, metallographic microscopes, X-ray diffractometers, and more [2][4]. - The expected procurement period is from July to September 2025 [2][4]. Group 2: Specific Equipment and Budget - The procurement includes: - Focused Ion Beam Scanning Electron Microscope (FIB+SEM) and other characterization equipment with a budget of 65 million yuan [4]. - Equipment for advanced micro-nano processing platform construction, including laser cutting machines and automated packaging machines, with a budget of 34 million yuan [4]. - Etching equipment for high-quality piezoelectric film preparation, with a budget of 55 million yuan [4]. - Integrated optical and semiconductor device simulation design software, with a budget of 45 million yuan [5].

Group 1 - The article emphasizes the importance of standardization in enterprises, highlighting it as a key aspect of corporate strategy [2] - A public live course titled "Standardization as Foundation, Strategy as Navigation - The Significance and Strategy of Standardization Work in Enterprises/Organizations" is scheduled for June 25, featuring expert Guo Xiaowei [2] - The course will cover various topics including the true meaning of standards and standardization, the current state and trends of domestic and international management systems, and the opportunities and challenges of enterprise standardization work [2] Group 2 - The article mentions the potential benefits of group standards and CIS standards in enhancing organizational effectiveness [2]

导读： 近日，清华大学发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行梳理，统计出29项仪器设备采购意向，预算 总额达1.00亿元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，清华大学发29项仪器设备采购意向，预算总额达1.00亿元，涉及聚焦离子束扫描电镜双（三）束系统、激光加 工精密五轴振镜及相关移动平台系统、光刻机、超声扫描显微镜、材料高通量全息形貌分析仪等，预计采购时间为 2025年6月。 清华大学 202 5 年 6 月仪器设备采购 意向汇总表 | 采购 | 需求概况 | 预算 | 采购 | | --- | --- | --- | --- | | 项目 | | 万元 | 时间 | | 聚焦离子束扫描电镜双（三） | 聚焦离子束扫描电镜双（三）束 | 1000 | 202 5 | | 束系统 | 系统。 | | 年 6 月 | | 激光加工精密五轴振镜及相关 | 激光加工精密五轴振镜及相关移 | 560 | 202 5 | | 移动平台系统 | 动平台系统 。 | | 年 6 月 | | 车用人工智能教学云端训练 ...

Core Viewpoint - The launch of China's first 200kV field emission transmission electron microscope by Bozhong Instruments marks a significant breakthrough in high-end scientific instruments, breaking international monopolies and entering a new era of independent research and commercialization in China [1][3]. Group 1 - Bozhong Instruments will hold a grand ceremony for the launch of the first domestic 200kV field emission transmission electron microscope on June 28 [3]. - The development process took five years, relying on fully independent and controllable electronic optical core technology, high stability low ripple power supply, and precise processing and assembly techniques [3]. - The successful integration of core technology breakthroughs into high-end equipment industrialization represents a new milestone in China's high-end scientific instrument autonomy [3].

导读： InfinityBio完成800万美元A轮融资，收购Serimmune资产，推进MIPSA抗体分析平台开发，计划2025年推出新服务。 Infinit y Bio 周三表示，已经完成了 800 万美元的 A 轮融资。并以未披露的金额收购了免疫分析公司 Serimmune 的资产，Serimmune 成立于 2014 年，旨在提供无偏差的抗体反应组服务。包括 Env iroSIGHT 在内的新 MIPSA服务产品也预计将于 2025 年下半年推出。 本轮融资由 I l lumina Ventures 领投，PTX Capital、Blackbird BioVentures 和 Propel Baltimore Fund 参投。此前，该公司曾从包 括马里兰州的 PTX Capital 和 Blackbird BioVentures 在内的投资者那里筹集了 400 万美元的资金。Infinit y 表示，总部位于巴尔的摩 （美国马里兰州最大城市，美国大西洋沿岸重要海港城市），将利用这笔资金扩大其商业足迹，加速其 MIPSA 抗体分析平台的开发，并推出 新的免疫分析服务，收购 Serimmune 的资产是其扩 ...

Core Viewpoint - The article highlights the resilience and innovative vitality of China's scientific instrument industry in the face of global challenges, showcasing significant growth in overseas revenue among domestic listed companies [2][6]. Group 1: Overview of Overseas Revenue - In 2024, the total overseas revenue of 43 domestic listed instrument companies reached 34.707 billion yuan, marking a new high [6][10]. - Over 60% of the companies reported revenue growth, with 21 companies achieving over 100 million yuan in overseas revenue [6][10]. - The top five companies by overseas revenue are Mindray Medical (16.434 billion yuan), Sunny Optical (9.602 billion yuan), Libang Instruments (1.098 billion yuan), BGI Genomics (913 million yuan), and Huashengchang (717 million yuan) [3][6]. Group 2: Performance Analysis - Among the 43 companies, 27 experienced stable or significant growth, with notable examples including Wanyi Technology, which saw a 447.23% increase in overseas revenue [7][12]. - Conversely, 14 companies faced revenue declines, such as Gaode Infrared, which reported a 50.76% drop [7][15]. - Mindray Medical's overseas revenue accounted for 44.75% of its total revenue, reflecting the effectiveness of its globalization strategy [10][17]. Group 3: Market Dynamics - The article indicates a shift in the market, with three companies achieving over 1 billion yuan in overseas revenue, while 18 companies fall within the 100 million to 1 billion yuan range [13]. - Companies with overseas revenue constituting over 10% of total revenue increased to 22, indicating a growing trend in international market engagement [17]. - Wanyi Technology's strategy of "product leadership, quality excellence, competitive pricing, and superior service" has led to substantial growth in overseas markets [13][17]. Group 4: Emerging Companies - New entrants like Titan Technology and Lihua Technology reported 100% growth in overseas revenue, reflecting successful market expansion strategies [14]. - Titan Technology leveraged partnerships with overseas distributors and acquisitions to enhance its competitive brand presence [14]. Group 5: Future Outlook - Despite external uncertainties, the overall trend indicates a robust commitment from Chinese companies to expand in international markets, suggesting a "fast forward" approach to globalization [17].

Core Viewpoint - The article emphasizes the importance of plasmid extraction in life sciences, highlighting its relevance for professionals ranging from students to scientists and its critical role in molecular-level work [1][2]. Summary by Sections Essential Knowledge Points - A qualified plasmid consists of several key components, including the origin of replication (Ori), antibiotic resistance genes, multiple cloning sites (MCS), promoters/enhancers, terminators, and poly(A) signals [5][10][11][12]. - Understanding how to read plasmid maps is crucial, focusing on the location of Ori, selection markers, MCS, and the size of foreign DNA inserts [14][15][19][20]. - The principles of plasmid extraction involve separating plasmid DNA from chromosomal DNA and proteins, utilizing methods like alkaline lysis [21][24][26][28][29]. Common Methods for Plasmid Extraction - Plasmid extraction methods include alkaline lysis, boiling lysis, and silica membrane adsorption, each with specific advantages and disadvantages [37][39][40][45][46]. - Alkaline lysis is the most common method, effective for various E. coli strains, but can damage DNA if not performed correctly [41][43]. - Boiling lysis is quick and simple but may yield lower purity and stability [45]. - Silica membrane adsorption is widely used for its high purity and efficiency, though it can be more costly [46][47]. Considerations for Plasmid Extraction - Proper bacterial culture conditions are essential, including selecting appropriate strains and media, and controlling growth parameters [63][64]. - Careful handling during cell lysis and purification is necessary to avoid contamination and ensure high-quality plasmid DNA [65][66][67]. - Using nuclease-free materials and reagents is critical to prevent DNA degradation [68][69]. Methods to Improve Plasmid Extraction Concentration - Strategies to enhance plasmid DNA concentration include optimizing lysis conditions, ensuring complete enzymatic treatment, and increasing initial cell quantities [70][71][72][74]. - Proper sample storage and equipment maintenance are also important for achieving higher yields [75][77]. Small-Scale Plasmid Preparation - Plasmids are circular DNA molecules that can replicate independently within bacterial cells, making them ideal for gene cloning [78][79]. - The alkaline lysis method is commonly used for small-scale plasmid preparation, allowing for the removal of proteins and RNA [80][81]. - The extraction process typically involves bacterial growth, harvesting, lysis, and purification steps [82][83]. Common Issues and Solutions in Plasmid Extraction - Problems such as excessive bacterial culture volume or inadequate lysis can lead to low yields and purity, requiring adjustments in protocol [97][98].

Core Viewpoint - Bio-Rad has decided to suspend its previously announced tariff surcharge plan, indicating a commitment to support customers amid complex global logistics challenges [2]. Group 1 - Bio-Rad's Senior Vice President of Commercial Operations for the Americas, Ryan Short, stated that the company will not implement the temporary tariff surcharge initially considered on May 21 [2]. - The decision reflects Bio-Rad's ongoing dedication to customer support while closely monitoring the evolving situation [2]. - Analyst Tycho Peterson from Jefferies noted that Bio-Rad's change in stance suggests a lack of broad pricing power for its product portfolio, particularly for standardized reagents [2]. Group 2 - Peterson highlighted that as tariff-related disputes, especially those involving China, begin to ease, the need for additional surcharges may diminish [2]. - He emphasized that implementing a surcharge could lead to a more significant decline in demand than anticipated, making it necessary to cancel the plan to protect revenue and market share [2]. - Following the announcement, Bio-Rad's stock price saw a slight increase of 1%, reaching $231.89 on the New York Stock Exchange [2].

Core Viewpoint - The article highlights various high-paying job opportunities in the scientific instrument sector, emphasizing the demand for skilled professionals in sales and technical roles across different companies in China [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][20][21][22]. Job Opportunities - Shanghai Licheng Instrument Technology Co., Ltd. is seeking an international trade manager with a salary range of 12k-20k, requiring over 5 years of experience in foreign trade and team management [2]. - Jena Analytik is looking for a regional sales representative in Xi'an, offering a salary of 8k-15k, with a preference for candidates with over 3 years of sales experience in chemical analysis instruments [2]. - Shanghai Flash Spectrum Biotechnology Co., Ltd. is hiring an amino acid analyzer sales manager in Taiyuan, with a salary range of 12k-24k [3]. - Beijing Pulit Technology Instrument Co., Ltd. is recruiting a sales manager in Wuhan, offering a salary of 10k-15k, requiring 1-3 years of relevant experience [4]. - Ying Sheng Hengtai is looking for a regional sales manager in the environmental field in Tianjin, with a salary range of 8k-15k, requiring a background in related fields [5]. - Yi Lu Wu You is hiring a medical device sales representative in Wuhan, with a salary range of 5k-20k, requiring at least 2 years of relevant experience [6]. - Haineng Technology is seeking a sales engineer in Haikou, offering a salary of 8k-12k, with a preference for candidates with marketing experience in scientific instruments [7]. - Saikamu is looking for a regional sales manager in Hangzhou, with salary negotiable, open to fresh graduates [8]. - Guangzhou Hexin Instrument Co., Ltd. is hiring a sales engineer for environmental/laboratory direction in Hangzhou, with a salary range of 5k-10k [9]. - Chengbang Haoran Measurement and Control Technology is seeking a regional sales representative for centrifuges in Chengdu, with a salary range of 5k-10k [10]. After-sales Positions - Agilent Technologies (China) Co., Ltd. is hiring an after-sales engineer for laboratory project management in Nanjing, with a salary range of 13k-18k [11]. - Yuanwei Max is looking for an application engineer in multiple cities, offering a salary range of 7k-15k [12]. - Shanghai Kailai Instrument Co., Ltd. is seeking an after-sales assistant in Shanghai, with a salary range of 9k-11k [13]. - Boside Technology Co., Ltd. is hiring a technical engineer in Beijing, with a salary range of 8k-12k [14]. - Beijing Jingke Ruida Technology Co., Ltd. is looking for after-sales engineers in multiple cities, with a salary range of 6k-12k [15]. - Hunan Lingfeng Instrument Equipment Co., Ltd. is hiring after-sales engineers in Changsha, with a salary range of 6k-10k [16].